0001104659-23-061938.txt : 20230517 0001104659-23-061938.hdr.sgml : 20230517 20230517170530 ACCESSION NUMBER: 0001104659-23-061938 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230515 FILED AS OF DATE: 20230517 DATE AS OF CHANGE: 20230517 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WG Biotech ApS CENTRAL INDEX KEY: 0001753193 STATE OF INCORPORATION: G7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38650 FILM NUMBER: 23932703 BUSINESS ADDRESS: STREET 1: RUNGSTED STRANDVEJ 113 CITY: RUNGSTED KYST STATE: G7 ZIP: 2960 BUSINESS PHONE: 45-45-17-77-77 MAIL ADDRESS: STREET 1: RUNGSTED STRANDVEJ 113 CITY: RUNGSTED KYST STATE: G7 ZIP: 2960 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Y-mAbs Therapeutics, Inc. CENTRAL INDEX KEY: 0001722964 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 474619612 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 230 PARK AVENUE STREET 2: SUITE 3350 CITY: NEW YORK STATE: NY ZIP: 10169 BUSINESS PHONE: 212-847-9841 MAIL ADDRESS: STREET 1: 230 PARK AVENUE STREET 2: SUITE 3350 CITY: NEW YORK STATE: NY ZIP: 10169 4 1 tm2315932-2_4seq1.xml OWNERSHIP DOCUMENT X0407 4 2023-05-15 0 0001722964 Y-mAbs Therapeutics, Inc. YMAB 0001753193 WG Biotech ApS RUNGSTED STRANDVEJ 113 RUNGSTED KYST G7 2960 DENMARK 1 0 0 1 See remarks 0 Common Stock 2023-05-15 4 P 0 101740 9.6462 A 4280205 D This transaction was executed in multiple trades at prices ranging from $9.64 to $10.00. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff,the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. Johan Wedell-Wedellsborg is the majority owner of WG Biotech ApS and has sole voting and dispositive power over the shares of the Issuer held by WG Biotech ApS. Mr. Wedell-Wedellsborg serves as a director of the Issuer. In connection therewith, WG Biotech ApS may be deemed to be a director by deputization of the Issuer solely for purposes of Section 16(a) of the Exchange Act. As a result, WG Biotech ApS is listed as a "Reporting Person" in Item 1 and the "Director" box is marked in Item 4 of this Form 4. This filing shall not be deemed an admission by Reporting Person on this Form 4 that such person is a director of the Issuer by deputization. WG Biotech ApS By: /s/ Johan Wedell-Wedellsborg 2023-05-17